Skip to Content

Join the 'Copaxone' group to help and get support from people like you.

Copaxone News

FDA Approves Glatopa (glatiramer acetate) as the First Generic Competitor to Copaxone

Posted 23 Apr 2015 by Drugs.com

Holzkirchen, Germany, April 16, 2015 - Sandoz, a Novartis company, today announced the US approval of Glatopa, the first generic version of Teva's Copaxone (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy. "Sandoz, together with Momenta, is proud to be the first company to receive FDA approval for a substitutable generic version of this important therapy," said ...

Generic Copaxone Approved for Multiple Sclerosis

Posted 16 Apr 2015 by Drugs.com

THURSDAY, April 16, 2015 – The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis (MS). The brand-name drug is produced by Israel-based Teva Pharmaceuticals. It's approved to treat MS, a chronic central nervous system disease caused by an overly aggressive immune system that turns on the body ...

Teva Announces U.S. FDA Approval of Three-Times-a-Week Copaxone (glatiramer acetate injection) 40mg/mL

Posted 29 Jan 2014 by Drugs.com

JERUSALEM--(BUSINESS WIRE)--Jan. 28, 2014-- Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental new drug application (sNDA) for three-times-a-week Copaxone 40mg/mL, a new dose of Copaxone. This new formulation will allow for a less frequent dosing regimen administered subcutaneously for patients with r ...

Ask a Question

Further Information

Related Condition Support Groups

Multiple Sclerosis

Copaxone Patient Information at Drugs.com